In the mobile phase, solvent A was comprised of water/acetonitrile (95:5, v/v) with 20 mM ammonium acetate (NH 3 AC) and 20 mM ammonia (NH 3 OH) at pH 9
Manfredi Rizzo is former Director, Clinical Medical & Regulatory Department, Novo Nordisk Europe East and South and has given lectures, received honoraria and research support, and participated in conferences, advisory boards and clinical trials sponsored by pharmaceutical industry including Amgen, AstraZeneca, Boehringer Ingelheim, Kowa, Eli Lilly, Meda, Mylan, Merck Sharp & Dohme, Novo Nordisk, Novartis, Roche Diagnostics, Sanofi and Servier
Protein intake deserves special attention on GLP-1 therapy
Integrating Lifestyle Support for Best Results A great care plan looks at you as a whole person